Sign Out
Lipo-Dox, a liposome formulation, is doxorubicin hydrochloride encapsulated in liposomes with surface-bound methoxypolyethylene glycol (MPEG). This process is known as pegylation and protects liposomes from detection by the mononuclear phagocyte system (MPS), which increases blood circulation time.
Each Lipo-Dox vial contains pegylated liposomal doxorubicin HCl 2 mg/mL and delivers 10 ml (20 mg) in a concentrate for infusion for single intravenous use and is presented as a sterile, translucent, red suspension. The active ingredient of Lipo-Dox is doxorubicin HCl, a cytotoxic anthracycline antibiotic obtained from Streptomyces peucetius var. caesius.
Excipients/Inactive Ingredients: Each vial of product contains the following excipients: Cholesterol, Sucrose, Water for Injection.
